Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue Suppl 2
423 Treatment of relapsed and refractory lymphomas with nivolumab in a limited recourse country
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
423 Treatment of relapsed and refractory lymphomas with nivolumab in a limited recourse country
Free
Online download statistics by month:
Online download statistics by month: November 2022 to August 2024
Abstract
Full
Pdf
Nov 2022
423
0
17
Dec 2022
56
0
9
Jan 2023
14
0
4
Feb 2023
26
0
8
Mar 2023
10
0
2
Apr 2023
16
0
1
May 2023
22
0
5
Jun 2023
26
0
0
Jul 2023
24
0
6
Aug 2023
12
0
2
Sep 2023
6
0
1
Oct 2023
14
0
2
Nov 2023
18
0
2
Dec 2023
36
0
3
Jan 2024
24
0
2
Feb 2024
14
0
2
Mar 2024
36
0
0
Apr 2024
8
0
0
May 2024
30
0
3
Jun 2024
18
0
1
Jul 2024
30
0
3
Aug 2024
22
0
3
Total
885
0
76
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?